Flex,
Yes Alzheimers and Asthma was the other notable indication - talk about a good pump!
The Diamond has rediscovered his 'sales' skills - not holding back is he?
Is all this bravado just a show during negotiations with Big Pharma for DMD?
If ANP announce IP protection targeting those two indications - using the CD49d thesis, then it will be fireworks!
Theoretically - both can go straight to Phase 2.
.
Chart, page-2937
-
- There are more pages in this discussion • 2,969 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
